Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jun
29
2024
Cheers to this! Good News for the North Carolina Alcoholic Beverage Industry Ward and Smith, P.A.
Jun
28
2024
Biden-Harris Administration Announces Actions to Accelerate U.S. Domestic Biomanufacturing Capacity Bergeson & Campbell, P.C.
Jun
28
2024
Minnesota Department of Health Highlights Recent Publications on PFAS Bioaccumulation and PFAS in Infant Formula Bergeson & Campbell, P.C.
Jun
28
2024
Old North State Report – June 28, 2024 Nelson Mullins
Jun
28
2024
In Purdue Pharma, the Supreme Court Fires a Canon of Construction Through Non-Consensual Third-Party Releases (US) Squire Patton Boggs (US) LLP
Jun
28
2024
FDA Releases Update of Priority Guidance Topics for Foods Program Keller and Heckman LLP
Jun
28
2024
Codifying the Experimental Use Exception? USPTO Seeks Public Input Womble Bond Dickinson (US) LLP
Jun
28
2024
SCOTUS Update: Supreme Court Clarifies Organizational Standing in FDA-Related Ruling ArentFox Schiff LLP
Jun
27
2024
In Purdue Pharma, Supreme Court Rules That Nonconsensual Releases Are A Nonstarter Miller Canfield
Jun
27
2024
Aye, What’s the Deal with THCA? Unraveling Hemp’s Legal Knots Norris McLaughlin P.A.
Jun
27
2024
E for Effort? PI Analysis in Trade Secret Suit Riddled with Errors McDermott Will & Emery
Jun
26
2024
July 1 Deadline Looms for Cannabis Operators to Maintain and Renew Their Licenses by Entering into Labor Peace Agreements Sheppard, Mullin, Richter & Hampton LLP
Jun
26
2024
The 340B ‘Saga’ Continued: HRSA, States, and Drug Manufacturers Contest 340B Contract Pharmacy Restrictions in Court ArentFox Schiff LLP
Jun
26
2024
FDA Issues Warning Letter Related to Allergen Labeling Practices Keller and Heckman LLP
Jun
26
2024
CMS Issues FAQs to Aid Pharmacies in Preparing for Medicare Part B Coverage of PrEP Medications McDermott Will & Emery
Jun
26
2024
United States | AIC Special Report Notes 65% Growth in H-2 a Workers in US Agricultural Sector Berry Appleman & Leiden
Jun
25
2024
APHIS RFI Will Seek Comments on Options for Reducing Regulations for Modified Microbes Bergeson & Campbell, P.C.
Jun
25
2024
This Week in 340B: June 18 – 24, 2024 McDermott Will & Emery
Jun
25
2024
FDA Continues Response to Contaminated Applesauce Pouches Keller and Heckman LLP
Jun
25
2024
‘Big in a Small Town’: How Fast Food and QSRs are Transforming Small Town Dining ArentFox Schiff LLP
Jun
25
2024
Trending in Telehealth: June 4 – 10, 2024 McDermott Will & Emery
Jun
25
2024
China’s Supreme People’s Court Releases Two Recent Patent-Related Typical Anti-Monopoly Cases Schwegman, Lundberg & Woessner, P.A.
Jun
24
2024
China’s Supreme People’s Court: Drug Patent Reverse Payment Agreements May Violate the Anti-Monopoly Law Schwegman, Lundberg & Woessner, P.A.
Jun
24
2024
USPTO Publishes Drug Patent and Exclusivity Study Report Foley & Lardner LLP
Jun
24
2024
Healthcare Preview for the Week of: June 24, 2024 [Podcast] McDermott Will & Emery
Jun
21
2024
MoCRA Compliance: Key Legal Issues for Fashion Houses with Cosmetics ArentFox Schiff LLP
Jun
21
2024
CCC in Turmoil? Massachusetts Legislature Urged to Place Cannabis Control Commission in Receivership Blank Rome LLP
Jun
21
2024
Teva and DOJ May Reach Settlement in Closely Watched AKS Lawsuit ArentFox Schiff LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins